“…The cytotoxicity of curcumin analogs 1-9, 11-15 was assessed in B16 (murine melanoma) and L1210 (murine leukemia) cell lines using a 72 h continuous exposure MTT assay as previously described [14]. The concentration at which 50% cell growth was inhibited (IC 50 , μM) was determined for each compound in triplicate experiments.…”
Section: Cytotoxic Activity In Murine Cell Linesmentioning
confidence: 99%
“…L1210 and B16 cell lines were purchased from ATCC (Manassas, VA, USA) and were maintained as previously reported [14]. The microtubule disrupting effects were evaluated in A-10 cells by indirect immunofluorescent techniques as previously described [24].…”
Section: Biologymentioning
confidence: 99%
“…Curcumin analogs 1-15 were subjected to a continuous exposure 72 h MTT assay as described previously [14]. L1210 and B16 cell lines were purchased from ATCC (Manassas, VA, USA) and were maintained as previously reported [14].…”
Section: Biologymentioning
confidence: 99%
“…This is of particular interest to one of the author's laboratory, which has extensively studied the effects of combretasta-tin-A4 analogs, such as chalcones and diarylheterocycles, as mitotic inhibitors. Presumably, cytotoxicity is mediated, at least in part, by microtubule depolymerization and inhibition of tubulin polymerization [12][13][14][15][16][17].…”
Fifteen curcumin analogs were synthesized and tested for in-vitro cytotoxicity towards B16 and L1210 murine cancer cell lines using an MTT assay. Significant activity was discovered for two analogs: 8 (B16 IC 50 = 1.6 μM; L1210 IC 50 = 0.35 μM) and 9 (B16 IC 50 = 0.51 μM; L1210 IC 50 = 1.2 μM). Several other analogs exhibited notable cytotoxicity. The data from quantitative structureactivity relationships suggest that large electron-withdrawing substituents placed in the metaposition of the arylidene aryl rings enhance potencies. Compounds 8 and 9 were found using a cell-based assay to have virtually no effects on microtubules at concentrations up to 40 μM. These results suggest that tubulin inhibition is not the principal mechanism by which the curcumin analogs act.
“…The cytotoxicity of curcumin analogs 1-9, 11-15 was assessed in B16 (murine melanoma) and L1210 (murine leukemia) cell lines using a 72 h continuous exposure MTT assay as previously described [14]. The concentration at which 50% cell growth was inhibited (IC 50 , μM) was determined for each compound in triplicate experiments.…”
Section: Cytotoxic Activity In Murine Cell Linesmentioning
confidence: 99%
“…L1210 and B16 cell lines were purchased from ATCC (Manassas, VA, USA) and were maintained as previously reported [14]. The microtubule disrupting effects were evaluated in A-10 cells by indirect immunofluorescent techniques as previously described [24].…”
Section: Biologymentioning
confidence: 99%
“…Curcumin analogs 1-15 were subjected to a continuous exposure 72 h MTT assay as described previously [14]. L1210 and B16 cell lines were purchased from ATCC (Manassas, VA, USA) and were maintained as previously reported [14].…”
Section: Biologymentioning
confidence: 99%
“…This is of particular interest to one of the author's laboratory, which has extensively studied the effects of combretasta-tin-A4 analogs, such as chalcones and diarylheterocycles, as mitotic inhibitors. Presumably, cytotoxicity is mediated, at least in part, by microtubule depolymerization and inhibition of tubulin polymerization [12][13][14][15][16][17].…”
Fifteen curcumin analogs were synthesized and tested for in-vitro cytotoxicity towards B16 and L1210 murine cancer cell lines using an MTT assay. Significant activity was discovered for two analogs: 8 (B16 IC 50 = 1.6 μM; L1210 IC 50 = 0.35 μM) and 9 (B16 IC 50 = 0.51 μM; L1210 IC 50 = 1.2 μM). Several other analogs exhibited notable cytotoxicity. The data from quantitative structureactivity relationships suggest that large electron-withdrawing substituents placed in the metaposition of the arylidene aryl rings enhance potencies. Compounds 8 and 9 were found using a cell-based assay to have virtually no effects on microtubules at concentrations up to 40 μM. These results suggest that tubulin inhibition is not the principal mechanism by which the curcumin analogs act.
“…10,11) Further, 1,3,4-oxadiazoles are very good bioisosteres of amides and esters which can contribute substantially in increasing pharmacological activity by participating in hydrogen bonding interactions with the receptors. 12) Besides, it has been well documented that pyrazoles 13) and oxadiazoles 14,15) have cytotoxic activity. The therapeutic effects of compounds containing 1,3,4-thiadiazole rings have been studied for a number of pathological conditions including inflammation, 16,17) pain 18,19) and hypertension.…”
A new class of pyrrolyl/pyrazolyl arylaminosulfonylmethyl 1,3,4-oxadiazoles, 1,3,4-thiadiazoles, and 1,2,4-triazoles were prepared and tested for antimicrobial activity. Amongst the tested compounds, 5c displayed high antimicrobial activity.
An efficient route for the synthesis of a series of new hybrid isoxazole-triazole compounds in high yields and excellent regioselectivity starting from either 2-aryl-1,1-dichlorocyclopropanes or N-hydroxybenzimidoyl chlorides was developed. The synthesized isoxazole-triazole hybrids were evaluated for their biological activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.